High-risk HPV DNA detection by hybrid capture II: An adjunctive test for mildly abnormal cytologic smears in women ≥ 50 years of age

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 45, Issue 4, 2000, Pages 345-350

  Lin, Cheng Tao ^a   Tseng, Chih Jen ^a   Lai, Chyong Huey ^a,b   Hsueh, S ^a   Huang, Huei Jean ^a   Law, Kim Seng ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Cervix neoplasms; Hybrid Capture II; Mass screening; Pap smear; Papillomaviruses, human

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC ACCURACY; DNA DETERMINATION; EARLY DIAGNOSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; PAPANICOLAOU TEST; PRIORITY JOURNAL; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; WART VIRUS;

AGE FACTORS; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; DNA PROBES, HPV; DNA, VIRAL; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0034049088     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Zur Hausen H: Human papillomaviruses and their possible role in squamous cell carcinomas. Curr Top Microbiol Immunol 1977;782:1-30
2. Richart RM, Wright TC: Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 1993;71: 1413-1421
3. Reid R: Preinvasive disease. In Practical Gynecologic Oncology. Second edition. Edited by J Berek, NF Hacker. Baltimore, Williams & Wilkins, 1994, pp 201-241
4. Koss LG: The Papanicolaou test for cervical cancer detection: A triumph and a tragedy. JAMA 1989;261:737-743
5. Kurman RJ, Henson DE, Herbst AL, et al: Interim guidelines for management of abnormal cervical cytology. JAMA 1994; 271:1866-1869
6. Gustafsson L, Sparen P, Gustafsson M, et al: Low efficiency of cytologic screening for cancer in situ of the cervix in older women. Int J Cancer 1995;63:804-809
7. Fletcher A: Screening for cancer of the cervix in elderly women. Lancet 1990;335:97-99
8. Hutchinson ML, Agarwal P, Denault T, et al: A new look at cervical cytology: ThinPrep multicenter trial results. Acta Cytol 1992;36:499-504
9. Sherman ME, Schiffman MH, Lorincz A, et al: Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing. Cancer Cytopathol 1997;81:89-97
10. Greenberg MD, Campion MJ, Rutledge LH: Cervicography as an adjunct to cytologic screening. Obstet Gynecol Clin North Am 1993;20:13-29
11. Sherman ME, Schiffman M, Herreo R, et al: Performance of a semiautomated Papanicolaou smear screening system. Cancer 1998;84:273-280
12. Reid S, Greenberg MD, Lorincz A: Should cervical cytologic testing be augmented by cervicography or human papillomavirus deoxyribonucleic acid detection? Am J Obstet Gynecol 1991;164:1461-1471
13. Cox JT, Schiffman MH: An evaluation of human papillomavirus testing as part of referral to colposcopy clinics. Obstet Gynecol 1992;80:389-395
14. Jenkins D, Johnson CS, Gallivan S: Can papillomavirus testing be used to improve cervical cancer screening? Int J Cancer 1996;65:768-773
15. Kaufman RH, Adam E, Icenogle J, et al: Human papillomavirus testing as triage for atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesions: Sensitivity, specificity, and cost-effectiveness. Am J Obstet Gynecol 1997;177:930-936
16. Sigurdsson K, Arnadottir T, Snorradottir M, et al: Human papillomavirus (HPV) in an Icelandic population: The role of HPV DNA testing based on hybrid capture and PCR assays among women with screen-detected abnormal Pap smears. Int J Cancer 1997;72:446-452
17. Recio FO, Sahai Srivastava BI, Wong C, et al: The clinical value of Digene hybrid capture HPV DNA testing in a referral-based population with abnormal pap smears. Eur J Gynaecol Oncol 1998;19:203-208
18. Schiffman MH, Bauer HM, Hoover RN: Epidemiologic evidence showing that human papillomavirus infection causes cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85: 958-964
19. Bosch FX, Manos MM, Muñoz N, et al: Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995;87:796-802
20. Campion MJ, McCance DJ, Cuzick J: Progressive potential of mild cervical atypia: Prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-240
21. Koutsky LA, Holmes KK, Critchlow CW, et al: A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N Engl J Med 1992;327:1272-1278
22. Melkert PWJ, Hopman E, van den Brule AJC, et al: Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer 1993;53:919-923
23. Ho GYF, Bierman R, Beardsley L, et al: Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998;338:423-427
24. Nindl I, Lörincz A, Mielzynska I, et al: Human papillomavirus detection in cervical intraepithelial neoplasia by the second-generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998;10:49-56
25. Lai MS: The national plan for the control of cervical cancer (abstr). In Proceedings of the 1st Annual Terry Fox & Chang Gung Memorial Hospital International Cancer Symposium on Cervical Cancer, Taipei, 1997, p 33
26. Nasiell K, Roger V, Nasiell M: Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67: 665-669
27. Manos MM, Kinney WK, Sherman ME, et al: Identifying women with cervical neoplasia using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999;281:1605-1610